Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Intratumoral delivery of plasmid interleukin-12 via electroporation leads to regression of injected and non-injected tumors in Merkel cell carcinoma.

Bhatia S, Longino NV, Miller NJ, Kulikauskas RM, Iyer JG, Ibrani D, Blom A, Byrd DR, Parvathaneni U, Twitty CG, Campbell JS, Le MH, Gargosky S, Pierce RH, Heller R, Daud AI, Nghiem P.

Clin Cancer Res. 2019 Oct 3. pii: clincanres.0972.2019. doi: 10.1158/1078-0432.CCR-19-0972. [Epub ahead of print]

PMID:
31582519
2.

Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma.

Wirsching HG, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino PJ, Amankulor N, Campbell JS, McFerrin L, Pattwell SS, Ene C, Hicks A, Ball M, Yan J, Zhang J, Kumasaka D, Pierce RH, Weller M, Finer M, Quéva C, Glorioso JC, Houghton AM, Holland EC.

JCI Insight. 2019 Jul 11;4(13). pii: 128217. doi: 10.1172/jci.insight.128217. eCollection 2019 Jul 11.

3.

Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model.

Ishida E, Lee J, Campbell JS, Chakravarty PD, Katori Y, Ogawa T, Johnson L, Mukhopadhyay A, Faquin WC, Lin DT, Wirth LJ, Pierce RH, Pai SI.

Cancer Immunol Immunother. 2019 Aug;68(8):1273-1286. doi: 10.1007/s00262-019-02357-1. Epub 2019 Jun 26.

PMID:
31243491
4.

Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial.

Zhang S, Kohli K, Black RG, Yao L, Spadinger SM, He Q, Pillarisetty VG, Cranmer LD, Van Tine BA, Yee C, Pierce RH, Riddell SR, Jones RL, Pollack SM.

Cancer Immunol Res. 2019 Aug;7(8):1237-1243. doi: 10.1158/2326-6066.CIR-18-0940. Epub 2019 Jun 6.

PMID:
31171504
5.

Karenia brevis causes high mortality and impaired swimming behavior of Florida stone crab larvae.

Gravinese PM, Saso E, Lovko VJ, Blum P, Cole C, Pierce RH.

Harmful Algae. 2019 Apr;84:188-194. doi: 10.1016/j.hal.2019.04.007. Epub 2019 Apr 18.

PMID:
31128803
6.

Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma.

Stromnes IM, Burrack AL, Hulbert A, Bonson P, Black C, Brockenbrough JS, Raynor JF, Spartz EJ, Pierce RH, Greenberg PD, Hingorani SR.

Cancer Immunol Res. 2019 Jun;7(6):977-989. doi: 10.1158/2326-6066.CIR-18-0448. Epub 2019 Apr 26.

PMID:
31028033
7.

Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer.

Seo YD, Jiang X, Sullivan KM, Jalikis FG, Smythe KS, Abbasi A, Vignali M, Park JO, Daniel SK, Pollack SM, Kim TS, Yeung R, Crispe IN, Pierce RH, Robins H, Pillarisetty VG.

Clin Cancer Res. 2019 Jul 1;25(13):3934-3945. doi: 10.1158/1078-0432.CCR-19-0081. Epub 2019 Apr 2.

PMID:
30940657
8.

Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting.

Srivastava S, Salter AI, Liggitt D, Yechan-Gunja S, Sarvothama M, Cooper K, Smythe KS, Dudakov JA, Pierce RH, Rader C, Riddell SR.

Cancer Cell. 2019 Mar 18;35(3):489-503.e8. doi: 10.1016/j.ccell.2019.02.003.

PMID:
30889382
9.

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.

Garris CS, Arlauckas SP, Kohler RH, Trefny MP, Garren S, Piot C, Engblom C, Pfirschke C, Siwicki M, Gungabeesoon J, Freeman GJ, Warren SE, Ong S, Browning E, Twitty CG, Pierce RH, Le MH, Algazi AP, Daud AI, Pai SI, Zippelius A, Weissleder R, Pittet MJ.

Immunity. 2018 Dec 18;49(6):1148-1161.e7. doi: 10.1016/j.immuni.2018.09.024. Epub 2018 Dec 11.

PMID:
30552023
10.

Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy.

Mukhopadhyay A, Wright J, Shirley S, Canton DA, Burkart C, Connolly RJ, Campbell JS, Pierce RH.

Gene Ther. 2019 Feb;26(1-2):1-15. doi: 10.1038/s41434-018-0044-5. Epub 2018 Oct 15.

11.

Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA.

Paulson KG, Voillet V, McAfee MS, Hunter DS, Wagener FD, Perdicchio M, Valente WJ, Koelle SJ, Church CD, Vandeven N, Thomas H, Colunga AG, Iyer JG, Yee C, Kulikauskas R, Koelle DM, Pierce RH, Bielas JH, Greenberg PD, Bhatia S, Gottardo R, Nghiem P, Chapuis AG.

Nat Commun. 2018 Sep 24;9(1):3868. doi: 10.1038/s41467-018-06300-3.

12.

Development of an adaptive electroporation system for intratumoral plasmid DNA delivery.

Brown DW, Bahrami AJ, Canton DA, Mukhopadhyay A, Campbell JS, Pierce RH, Connolly RJ.

Bioelectrochemistry. 2018 Aug;122:191-198. doi: 10.1016/j.bioelechem.2018.04.005. Epub 2018 Apr 9.

PMID:
29660647
13.

The effects of red tide (Karenia brevis) on reflex impairment and mortality of sublegal Florida stone crabs, Menippe mercenaria.

Gravinese PM, Kronstadt SM, Clemente T, Cole C, Blum P, Henry MS, Pierce RH, Lovko VJ.

Mar Environ Res. 2018 Jun;137:145-148. doi: 10.1016/j.marenvres.2018.03.004. Epub 2018 Mar 12.

PMID:
29571587
14.

Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters.

Burkart C, Mukhopadhyay A, Shirley SA, Connolly RJ, Wright JH, Bahrami A, Campbell JS, Pierce RH, Canton DA.

Gene Ther. 2018 Apr;25(2):93-103. doi: 10.1038/s41434-018-0006-y. Epub 2018 Mar 9.

PMID:
29523878
15.

Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer.

Tchou J, Zhao Y, Levine BL, Zhang PJ, Davis MM, Melenhorst JJ, Kulikovskaya I, Brennan AL, Liu X, Lacey SF, Posey AD Jr, Williams AD, So A, Conejo-Garcia JR, Plesa G, Young RM, McGettigan S, Campbell J, Pierce RH, Matro JM, DeMichele AM, Clark AS, Cooper LJ, Schuchter LM, Vonderheide RH, June CH.

Cancer Immunol Res. 2017 Dec;5(12):1152-1161. doi: 10.1158/2326-6066.CIR-17-0189. Epub 2017 Nov 6.

16.

Dramatic enhancement of the detection limits of bioassays via ultrafast deposition of polydopamine.

Li J, Baird MA, Davis MA, Tai W, Zweifel LS, Adams Waldorf KM, Gale M Jr, Rajagopal L, Pierce RH, Gao X.

Nat Biomed Eng. 2017;1. pii: 0082. doi: 10.1038/s41551-017-0082. Epub 2017 Jun 5.

17.

T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma.

Stromnes IM, Hulbert A, Pierce RH, Greenberg PD, Hingorani SR.

Cancer Immunol Res. 2017 Nov;5(11):978-991. doi: 10.1158/2326-6066.CIR-16-0322. Epub 2017 Oct 24.

18.

Melanoma treatment with intratumoral electroporation of tavokinogene telseplasmid (pIL-12, tavokinogene telseplasmid).

Canton DA, Shirley S, Wright J, Connolly R, Burkart C, Mukhopadhyay A, Twitty C, Qattan KE, Campbell JS, Le MH, Pierce RH, Gargosky S, Daud A, Algazi A.

Immunotherapy. 2017 Dec;9(16):1309-1321. doi: 10.2217/imt-2017-0096. Epub 2017 Oct 24.

19.

PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4+ TILs in the Presence of PD-L1+ TAMs.

Mattox AK, Lee J, Westra WH, Pierce RH, Ghossein R, Faquin WC, Diefenbach TJ, Morris LG, Lin DT, Wirth LJ, Lefranc-Torres A, Ishida E, Chakravarty PD, Johnson L, Zeng YC, Chen H, Poznansky MC, Iyengar NM, Pai SI.

Cancer Res. 2017 Nov 15;77(22):6365-6374. doi: 10.1158/0008-5472.CAN-16-3453. Epub 2017 Sep 25.

20.

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden GGGM, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, Comerma L, Thompson EA, Lakhani S, Kim SR, Schnitt S, Colpaert C, Sotiriou C, Scherer SJ, Ignatiadis M, Badve S, Pierce RH, Viale G, Sirtaine N, Penault-Llorca F, Sugie T, Fineberg S, Paik S, Srinivasan A, Richardson A, Wang Y, Chmielik E, Brock J, Johnson DB, Balko J, Wienert S, Bossuyt V, Michiels S, Ternes N, Burchardi N, Luen SJ, Savas P, Klauschen F, Watson PH, Nelson BH, Criscitiello C, O'Toole S, Larsimont D, de Wind R, Curigliano G, André F, Lacroix-Triki M, van de Vijver M, Rojo F, Floris G, Bedri S, Sparano J, Rimm D, Nielsen T, Kos Z, Hewitt S, Singh B, Farshid G, Loibl S, Allison KH, Tung N, Adams S, Willard-Gallo K, Horlings HM, Gandhi L, Moreira A, Hirsch F, Dieci MV, Urbanowicz M, Brcic I, Korski K, Gaire F, Koeppen H, Lo A, Giltnane J, Rebelatto MC, Steele KE, Zha J, Emancipator K, Juco JW, Denkert C, Reis-Filho J, Loi S, Fox SB.

Adv Anat Pathol. 2017 Nov;24(6):311-335. doi: 10.1097/PAP.0000000000000161. Review.

21.

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.

Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden GGGM, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, Comerma L, Thompson EA, Lakhani S, Kim SR, Schnitt S, Colpaert C, Sotiriou C, Scherer SJ, Ignatiadis M, Badve S, Pierce RH, Viale G, Sirtaine N, Penault-Llorca F, Sugie T, Fineberg S, Paik S, Srinivasan A, Richardson A, Wang Y, Chmielik E, Brock J, Johnson DB, Balko J, Wienert S, Bossuyt V, Michiels S, Ternes N, Burchardi N, Luen SJ, Savas P, Klauschen F, Watson PH, Nelson BH, Criscitiello C, O'Toole S, Larsimont D, de Wind R, Curigliano G, André F, Lacroix-Triki M, van de Vijver M, Rojo F, Floris G, Bedri S, Sparano J, Rimm D, Nielsen T, Kos Z, Hewitt S, Singh B, Farshid G, Loibl S, Allison KH, Tung N, Adams S, Willard-Gallo K, Horlings HM, Gandhi L, Moreira A, Hirsch F, Dieci MV, Urbanowicz M, Brcic I, Korski K, Gaire F, Koeppen H, Lo A, Giltnane J, Rebelatto MC, Steele KE, Zha J, Emancipator K, Juco JW, Denkert C, Reis-Filho J, Loi S, Fox SB.

Adv Anat Pathol. 2017 Sep;24(5):235-251. doi: 10.1097/PAP.0000000000000162. Review.

22.

Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC.

Tumeh PC, Hellmann MD, Hamid O, Tsai KK, Loo KL, Gubens MA, Rosenblum M, Harview CL, Taube JM, Handley N, Khurana N, Nosrati A, Krummel MF, Tucker A, Sosa EV, Sanchez PJ, Banayan N, Osorio JC, Nguyen-Kim DL, Chang J, Shintaku IP, Boasberg PD, Taylor EJ, Munster PN, Algazi AP, Chmielowski B, Dummer R, Grogan TR, Elashoff D, Hwang J, Goldinger SM, Garon EB, Pierce RH, Daud A.

Cancer Immunol Res. 2017 May;5(5):417-424. doi: 10.1158/2326-6066.CIR-16-0325. Epub 2017 Apr 14.

23.

Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma.

Daud AI, Loo K, Pauli ML, Sanchez-Rodriguez R, Sandoval PM, Taravati K, Tsai K, Nosrati A, Nardo L, Alvarado MD, Algazi AP, Pampaloni MH, Lobach IV, Hwang J, Pierce RH, Gratz IK, Krummel MF, Rosenblum MD.

J Clin Invest. 2016 Sep 1;126(9):3447-52. doi: 10.1172/JCI87324. Epub 2016 Aug 15.

24.

Effects of field and laboratory exposure to the toxic dinoflagellate Karenia brevis on the reproduction of the eastern oyster, Crassostrea virginica, and subsequent development of offspring.

Rolton A, Vignier J, Volety AK, Pierce RH, Henry M, Shumway SE, Bricelj VM, Hégaret H, Soudant P.

Harmful Algae. 2016 Jul;57(Pt A):13-26. doi: 10.1016/j.hal.2016.04.011. Epub 2016 Jun 2.

PMID:
30170718
25.

Seed viability and germination success of Acacia tortilis along land-use and aridity gradients in the Eastern Sahara.

Andersen GL, Krzywinski K, Gjessing HK, Pierce RH.

Ecol Evol. 2015 Dec 29;6(1):256-66. doi: 10.1002/ece3.1851. eCollection 2016 Jan.

26.

Characterization of an epoxide hydrolase from the Florida red tide dinoflagellate, Karenia brevis.

Sun P, Leeson C, Zhi X, Leng F, Pierce RH, Henry MS, Rein KS.

Phytochemistry. 2016 Feb;122:11-21. doi: 10.1016/j.phytochem.2015.11.002. Epub 2015 Nov 25.

27.

In-situ tumor vaccination: Bringing the fight to the tumor.

Pierce RH, Campbell JS, Pai SI, Brody JD, Kohrt HE.

Hum Vaccin Immunother. 2015;11(8):1901-9. doi: 10.1080/21645515.2015.1049779. Review.

28.

Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors.

Patnaik A, Kang SP, Rasco D, Papadopoulos KP, Elassaiss-Schaap J, Beeram M, Drengler R, Chen C, Smith L, Espino G, Gergich K, Delgado L, Daud A, Lindia JA, Li XN, Pierce RH, Yearley JH, Wu D, Laterza O, Lehnert M, Iannone R, Tolcher AW.

Clin Cancer Res. 2015 Oct 1;21(19):4286-93. doi: 10.1158/1078-0432.CCR-14-2607. Epub 2015 May 14.

29.

Biomarkers of brevetoxin exposure and composite toxin levels in hard clam (Mercenaria sp.) exposed to Karenia brevis blooms.

Abraham A, El Said KR, Wang Y, Jester EL, Plakas SM, Flewelling LJ, Henry MS, Pierce RH.

Toxicon. 2015 Mar;96:82-8. doi: 10.1016/j.toxicon.2015.01.014. Epub 2015 Jan 22.

PMID:
25620222
30.

PD-1 blockade induces responses by inhibiting adaptive immune resistance.

Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, West AN, Carmona M, Kivork C, Seja E, Cherry G, Gutierrez AJ, Grogan TR, Mateus C, Tomasic G, Glaspy JA, Emerson RO, Robins H, Pierce RH, Elashoff DA, Robert C, Ribas A.

Nature. 2014 Nov 27;515(7528):568-71. doi: 10.1038/nature13954.

31.

Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells.

Chan IH, Jain R, Tessmer MS, Gorman D, Mangadu R, Sathe M, Vives F, Moon C, Penaflor E, Turner S, Ayanoglu G, Chang C, Basham B, Mumm JB, Pierce RH, Yearley JH, McClanahan TK, Phillips JH, Cua DJ, Bowman EP, Kastelein RA, LaFace D.

Mucosal Immunol. 2014 Jul;7(4):842-56. doi: 10.1038/mi.2013.101. Epub 2013 Nov 27.

PMID:
24280935
32.

Killer T cells find meaningful encounters through iMATEs.

Crispe IN, Pierce RH.

Nat Immunol. 2013 Jun;14(6):533-4. doi: 10.1038/ni.2620. No abstract available.

PMID:
23685817
33.

Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease.

Cayatte C, Joyce-Shaikh B, Vega F, Boniface K, Grein J, Murphy E, Blumenschein WM, Chen S, Malinao MC, Basham B, Pierce RH, Bowman EP, McKenzie BS, Elson CO, Faubion WA, Malefyt Rde W, Kastelein RA, Cua D, McClanahan TK, Beaumont M.

Clin Transl Gastroenterol. 2012 Feb 16;3:e10. doi: 10.1038/ctg.2012.2.

34.

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells.

Sherlock JP, Joyce-Shaikh B, Turner SP, Chao CC, Sathe M, Grein J, Gorman DM, Bowman EP, McClanahan TK, Yearley JH, Eberl G, Buckley CD, Kastelein RA, Pierce RH, Laface DM, Cua DJ.

Nat Med. 2012 Jul 1;18(7):1069-76. doi: 10.1038/nm.2817.

PMID:
22772566
35.

Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice.

Cheung R, Shen F, Phillips JH, McGeachy MJ, Cua DJ, Heyworth PG, Pierce RH.

J Clin Invest. 2011 Nov;121(11):4446-61. doi: 10.1172/JCI57682. Epub 2011 Oct 17.

36.

Ineffective CD8(+) T-cell immunity to adeno-associated virus can result in prolonged liver injury and fibrogenesis.

Spahn J, Pierce RH, Crispe IN.

Am J Pathol. 2011 Nov;179(5):2370-81. doi: 10.1016/j.ajpath.2011.08.004. Epub 2011 Sep 15.

37.

C17 prevents inflammatory arthritis and associated joint destruction in mice.

Chao C, Joyce-Shaikh B, Grein J, Moshrefi M, Raoufi F, Laface DM, McClanahan TK, Bourne PA, Pierce RH, Gorman DM, Pflanz S.

PLoS One. 2011;6(7):e22256. doi: 10.1371/journal.pone.0022256. Epub 2011 Jul 25.

38.

IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass.

Adamopoulos IE, Tessmer M, Chao CC, Adda S, Gorman D, Petro M, Chou CC, Pierce RH, Yao W, Lane NE, Laface D, Bowman EP.

J Immunol. 2011 Jul 15;187(2):951-9. doi: 10.4049/jimmunol.1003986. Epub 2011 Jun 13.

39.

Compositional changes in neurotoxins and their oxidative derivatives from the dinoflagellate, Karenia brevis, in seawater and marine aerosol.

Pierce RH, Henry MS, Blum PC, Osborn SE, Cheng YS, Zhou Y, Irvin CM, Bourdelais AJ, Naar J, Baden DG.

J Plankton Res. 2011 Feb;33(2):343-348. Epub 2010 Sep 9.

40.

Phenotypic enhancement of thymidylate synthetase pathway inhibitors following ablation of Neil1 DNA glycosylase/lyase.

Taricani L, Shanahan F, Pierce RH, Guzi TJ, Parry D.

Cell Cycle. 2010 Dec 15;9(24):4876-83. Epub 2010 Dec 15.

PMID:
21131780
41.

Personal exposure to aerosolized red tide toxins (brevetoxins).

Cheng YS, Zhou Y, Naar J, Irvin CM, Su WC, Fleming LE, Kirkpatrick B, Pierce RH, Backer LC, Baden DG.

J Occup Environ Hyg. 2010 Jun;7(6):326-31. doi: 10.1080/15459621003724041. Erratum in: J Occup Environ Hyg. 2011 Sep;8(9):D88.

PMID:
20379895
42.

IL-33 induces IL-13-dependent cutaneous fibrosis.

Rankin AL, Mumm JB, Murphy E, Turner S, Yu N, McClanahan TK, Bourne PA, Pierce RH, Kastelein R, Pflanz S.

J Immunol. 2010 Feb 1;184(3):1526-35. doi: 10.4049/jimmunol.0903306. Epub 2009 Dec 30.

43.

Characterization of Florida red tide aerosol and the temporal profile of aerosol concentration.

Cheng YS, Zhou Y, Pierce RH, Henry M, Baden DG.

Toxicon. 2010 May;55(5):922-9. doi: 10.1016/j.toxicon.2009.10.016. Epub 2009 Oct 29.

44.

Solid polymeric microparticles enhance the delivery of siRNA to macrophages in vivo.

Lee S, Yang SC, Kao CY, Pierce RH, Murthy N.

Nucleic Acids Res. 2009 Dec;37(22):e145. doi: 10.1093/nar/gkp758.

45.

Hepatitis C virus core protein subverts the antiviral activities of human Kupffer cells.

Tu Z, Pierce RH, Kurtis J, Kuroki Y, Crispe IN, Orloff MS.

Gastroenterology. 2010 Jan;138(1):305-14. doi: 10.1053/j.gastro.2009.09.009. Epub 2009 Sep 19.

PMID:
19769973
46.

Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling.

Clementi AH, Gaudy AM, van Rooijen N, Pierce RH, Mooney RA.

Biochim Biophys Acta. 2009 Nov;1792(11):1062-72. doi: 10.1016/j.bbadis.2009.08.007. Epub 2009 Aug 20.

47.
48.

Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation.

Kleinschek MA, Boniface K, Sadekova S, Grein J, Murphy EE, Turner SP, Raskin L, Desai B, Faubion WA, de Waal Malefyt R, Pierce RH, McClanahan T, Kastelein RA.

J Exp Med. 2009 Mar 16;206(3):525-34. doi: 10.1084/jem.20081712. Epub 2009 Mar 9.

49.

Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice.

Jin X, Zimmers TA, Zhang Z, Pierce RH, Koniaris LG.

Gut. 2010 Feb;59(2):186-96. doi: 10.1136/gut.2008.151175. Epub 2008 Dec 11.

PMID:
19074180
50.

Cellular metabolism of brevetoxin (PbTx-2) by a monocyte cell line (U-937).

Walsh CJ, Leggett SR, Henry MS, Blum PC, Osborn S, Pierce RH.

Toxicon. 2009 Jan;53(1):135-45. doi: 10.1016/j.toxicon.2008.10.024. Epub 2008 Nov 7.

PMID:
19027773

Supplemental Content

Loading ...
Support Center